Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Connective Tissue Diseases

• A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung Disease
• 129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH)
• A Study of Peresolimab (LY3462817) in Participants With Moderately-to-Severely Active Rheumatoid Arthritis
• Efficacy and Immune Function of Pirfenidone in CTD-ILD
• Percutaneous Needle Fasciotomy +/- Corticosteroid Injection for Dupuytren's Contracture
• Residual Disease MEMory in PSOriasis Skin During EnstiLAR® and Narrow-band Ultraviolet B Therapy: The MEMPSOLAR Study
• Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies
• A Study to Evaluate the Safety, Tolerability and Efficacy of MHV370 in Participants With Sjogren's Syndrome (SjS) or Mixed Connective Tissue Disease (MCTD)
• Pilot Study Assessing the Effect of Tildrakizumab in Vitiligo
• Immunosuppressant Combined With Pirfenidone in CTD-ILD
• Eltrombopag Combined With Low-dose Rituximab in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies
• Effect of Sacubitril/Valsartan on Reduced Right Ventricular Ejection Fraction in Patients With CTD
• Novel Form of Acquired Long QT Syndrome
• A Study of Ralinepag to Evaluate Effects on Exercise Capacity by CPET in Subjects With WHO Group 1 PH
• Study of Sirolimus in CTD-TP in China
• A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
• Immunosuppressant Regimens for Living Fetuses Study
• A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients
• Study of Neoadjuvant Checkpoint Blockade in Patients With Surgically Resectable Undifferentiated Pleomorphic Sarcoma and Dedifferentiated Liposarcoma
• Safety and Tolerability of Topically Applied Bovine Lung Surfactant on Intact Skin
• Efficacy and Safety of Vascana® in Subjects With Secondary Raynaud's Phenomenon
• Oral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial Hypertension
• Bardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYST
• A Psoriasis Plaque Test Trial With LEO 90100 Compared to Betesil® in Patients With Psoriasis Vulgaris
• A Psoriasis Plaque Test Trial With LP0113 Spray in Patients With Psoriasis Vulgaris (LP0113-1123)
• A Clinical Trial to Assess the Potential of LEO 130852A Gel to Reduce Steroid Induced Skin Atrophy on Healthy Skin
• Skin Irritation Test of LEO 80185 Gel in Healthy Japanese Subjects
• A Single-Centre Clinical Trial to Assess Steroid Induced Skin Atrophy on Healthy Skin
• A Phase 4 Trial Assessing the ImPact of Residual Inflammation Detected Via Imaging TEchniques, Drug Levels and Patient Characteristics on the Outcome of Dose TaperIng of Adalimumab in Clinical Remission Rheumatoid ArThritis (RA) Subjects (PREDICTRA)
• VasoREACTivity Testing With Intravenous SILdenafil in Patients With Precapillary Pulmonary Hypertension
• Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD
• Testing Effectiveness of Losartan in Patients With EoE With or Without a CTD
• Study of Trimethoprim/Sulfamethoxazole as PCP Prophylaxis in CTD Patients
• On Open-Label Study in Participants With Systemic Lupus Erythematosus
• Anakinra for Behcet s Disease
• A Clinical Trial for CTD-ILD Treatment
• A Study of LY2127399 in Participants With Systemic Lupus Erythematosus
• A Study of LY2127399 in Participants With Systemic Lupus Erythematosus
• A Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic Sclerosis
• A Study to Evaluate the Use of Bosentan in Patients With Exercise Induced Pulmonary Arterial Hypertension Associated With Connective Tissue Disease
• Time To Efficacy and Onset Of Action Of Linezolid
• Oral Type I Collagen for Relieving Scleroderma
• Absorption of Corticosteroids in Children With Juvenile Dermatomyositis